本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

14.00
0.0000
成交量:- -
成交额:- -
市值:10.05亿
市盈率:-9.34
高:14.00
开:14.00
低:14.00
收:14.00
52周最高:25.00
52周最低:0.7830
股本:7,175.01万
流通股本:5,355.59万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.4991
每股收益(LYR):-1.9732
净资产收益率:-45.35%
总资产收益率:-28.47%
市净率:5.25
市盈率(LYR):-7.10

数据加载中...

2026/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/04

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/04

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/04

重要事件披露

Form 8-K - Current report
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/07

重要事件披露

Form 8-K - Current report
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/22

重要事件披露

Form 8-K - Current report
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report
2025/06/17

重要事件披露

Form 8-K - Current report
2025/06/10

重要事件披露

Form 8-K - Current report
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]